Cathie Wood, Ark Investment’s chief executive, has said that the "most underappreciated application of AI" is health care.

Although buying the dip is never a sure bet, iconic investor Cathie Wood believes loading up on shares of beaten-down Tempus AI (TEM) now is a great move. Yet to be profitable, Tempus has notable ...

Of the 30 companies on the list, 22 firms saw their share prices decline month over month, while eight companies saw their stock prices rise.

BofA raised the firm’s price target on Tempus AI (TEM) to $60 from $54 and keeps a Neutral rating on the shares after the company reported Q4 ...

Tempus AI, Nancy Pelosi's latest stock bet, crashed by 27% in a week — but its long-term prospects could still be intact.

A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...

The acquisition of Ambry Genetics strengthens Tempus AI's genomics capabilities by adding a West Coast lab and expanding ...

Cathie Wood doubled down on Tempus AI, despite the fact that TEM stock erased most of the gains made in the past month.

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...

CompanyOverview\|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Tempus posted a fourth-quarter adjusted net loss of $0.18 per share, $0.02 more per share than estimates by analysts surveyed ...

Tempus AI, Inc. TEM reported fourth-quarter 2024 adjusted loss per share of 18 cents, which missed the Zacks Consensus ...